Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
PMV Pharmaceuticals, Inc
NeoImmuneTech
Neonc Technologies, Inc.
Merck Sharp & Dohme LLC
ImmunityBio, Inc.
VM Oncology, LLC
Amgen
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Blanco, Dr Antonio Calles MD
Seagen Inc.
Sotio Biotech Inc.
Carisma Therapeutics Inc
Sellas Life Sciences Group
Salubris Biotherapeutics Inc
Evopoint Biosciences Inc.
University of Florida
European Organisation for Research and Treatment of Cancer - EORTC
Fate Therapeutics
Xencor, Inc.
Alliance Foundation Trials, LLC.
Merck Sharp & Dohme LLC
NYU Langone Health
Aeglea Biotherapeutics
MultiVir, Inc.
Incyte Corporation
Seoul National University Hospital
Western Regional Medical Center